MOLECULAR PARTNERS AND NOVARTIS REPORT POSITIVE TOPLINE DATA FROM PHASE 2 STUDY FOR ENSOVIBEP (MP0420), A DARPIN ANTIVIRAL THERAPEUTIC FOR COVID-19 https://t.co/CVxYdya9Cx
Flourish Research Adds Great Lakes Clinical Trials and Clinical Site Partners to the Network, Tripling Revenue and Expanding Clinical Expertise in Six Months https://t.co/hGDaTe0LYn
Great Lakes Clinical Trials Doses First Patient in a Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD) https://t.co/Z0QmnZGDDN
Congrats to Eagle Award recipients @PPDCRO and @pfizer - bravo and well deserved. Thank you for the work you have done and to ALL of this year’s nominees #SCRS21#courageandvision
“As a member of a community disproportionately affected by COVID-19, I wanted to be a part of the solution to this crisis.” Lynne Jordan, a COVID-19 vaccine clinical trial participant shares her experience at AWARE for All – Midwest. https://t.co/2oOifYXLCp